[KClientError] [REQ_ERR: OPERATION_TIMEDOUT] [KTrafficClient] Something is wrong.
Global Allergy Diagnostics Market
Healthcare Services

Allergy Diagnostics Market Expected To Reach $13.02 Billion By 2030 As Growth Accelerates At 13.2% CAGR

Through market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports provide more actionable and strategically valuable research.

Allergy Diagnostics Market Expansion Outlook: What Revenue Opportunities Lie Ahead?

The sector dedicated to allergy diagnostics has experienced a significant upswing lately. Projections indicate a rise from a valuation of $6.99 billion in 2025 to $7.94 billion by 2026, reflecting a compound annual growth rate of 13.5%. Factors contributing to this expansion during the preceding period include the escalating incidence of allergic conditions globally, a greater uptake of skin prick and intradermal testing methodologies, the proliferation of laboratory facilities within hospital settings, heightened public consciousness regarding allergy management strategies, and the constrained accessibility of sophisticated in-vitro testing kits.

The global market for allergy diagnostics is poised for substantial expansion over the coming years, projecting a reach of $13.03 billion by 2030, driven by a compound annual growth rate of 13.2%. This anticipated surge is a direct result of several key factors, including advancements in component-resolved diagnostics, the increasing integration of automated systems in allergy testing procedures, heightened investments in exploring novel allergens through research initiatives, the proliferation of academic and diagnostic laboratories, and a growing consumer desire for tailored allergy treatment plans. Throughout this forecast period, dominant trends will include a persistent demand for highly accurate diagnostic solutions, a widening embrace of in-vitro testing methodologies, the continuous expansion of food and drug allergen assessments, a more extensive utilization of ELISA, RAST, and CRD kits, and a pronounced focus on developing rapid, point-of-care allergy detection methods.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=5655&type=smp

#Allergy Diagnostics Market Growth Drivers And Industry Catalysts

The escalating incidence of allergic conditions is set to be a significant driver for the expansion of the allergy diagnostics market, with environmental factors such as industrial and vehicular emissions being key contributors to this upward trend in allergy prevalence, whereas an allergic reaction itself is characterized by an aberrant immune system reaction to a specific allergen, encompassing a range of conditions including anaphylaxis, allergic rhinitis commonly known as ‘hay fever,’ sensitivities to food, skin reactions, and allergic asthma, and the primary strategy for managing these allergic disorders involves stringent avoidance of the triggering allergen, underscoring the criticality of accurate allergy diagnosis for successful therapeutic interventions, for example, Anaphylaxis UK, a UK charity, reported in September 2024 that food allergy reactions manifest in school settings 20% of the time, with a concerning statistic of one in five children with food allergies facing bullying and an equivalent proportion of parents experiencing moderate to extreme anxiety, furthermore, nearly all parents of children with allergies exhibit symptoms of post-traumatic stress symptoms (PTSS), a rate sevenfold higher among those whose children require adrenaline auto-injectors (AAIs), consequently, the growing prevalence of allergic diseases will undoubtedly bolster the growth trajectory of the allergic diagnostics market.

Allergy Diagnostics Market Segment Breakdown: Which Categories Generate The Most Revenue?

The allergy diagnostics market covered in this report is segmented –

1) By Test Type: In-Vivo Allergy Tests, In-Vitro Allergy Tests

2) By Allergen: Inhaled Allergens, Food Allergens, Drug Allergens

3) By Products: Consumables, Instruments

4) By End User: Diagnostics Laboratories, Hospital-based Laboratories, Academic and Research Institutes

Subsegments:

1) By In-Vivo Allergy Tests: Skin Prick Tests, Intradermal Tests, Patch Tests, Oral Food Challenge Tests

2) By In-Vitro Allergy Tests: Enzyme-Linked Immunosorbent Assay (ELISA), Radioallergosorbent Test (RAST), Component-Resolved Diagnostics (CRD), Basophil Activation Tests (BAT)

#Allergy Diagnostics Market Trends Influencing Long-Term Demand

Leading entities within the allergy diagnostics sector are actively pursuing novel technological advancements, exemplified by an AI-driven platform for allergy component analysis, as a strategy to enhance their market profitability. This sophisticated system leverages artificial intelligence to meticulously examine and interpret the outcomes of allergy testing. As a concrete illustration, Metropolis, a diagnostic provider situated in India, introduced in May 2023 an AI-powered allergy component testing solution capable of identifying 127 airborne allergens, 10 allergens causing skin reactions, and 158 food-related allergens, thereby offering profound insights for tailoring and refining patient treatment plans and assisting healthcare professionals in making informed clinical judgments through the integration of component-resolved diagnostics and artificial intelligence.

Allergy Diagnostics Market Key Players And Strategic Industry Positioning

Major companies operating in the allergy diagnostics market are bioMérieux SA, Danaher Corporation, HOB Biotech Group Corp. Ltd., HYCOR Biomedical, Lincoln Diagnostics Inc., Omega Diagnostics Group PLC, Siemens Healthineers AG, Thermo Fisher Scientific Inc., PerkinElmer Inc., R-Biopharm AG, Abbott Laboratories, HollisterStier Allergy, NEOGEN Corporation, AESKU.GROUP GmbH, ACON Laboratories Inc., Erba Group, Stallergenes Greer, HAL Allergy Group, INDOOR Biotechnologies Inc., MacroArray Technologies LLC, Phadia AB, Quest Diagnostics, Randox Laboratories Ltd., Eurofins Viracor Inc., VRL Laboratories

Access The Complete Allergy Diagnostics Market Report:

https://www.thebusinessresearchcompany.com/report/allergy-diagnostics-global-market-report

Allergy Diagnostics Market Leading Geography: Which Region Generates The Most Revenue?

North America was the largest region in the allergy diagnostics market in 2025. The regions covered in the allergy diagnostics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

[KClientError] [REQ_ERR: OPERATION_TIMEDOUT] [KTrafficClient] Something is wrong.

Leave a Reply

Your email address will not be published. Required fields are marked *

[KClientError] [REQ_ERR: OPERATION_TIMEDOUT] [KTrafficClient] Something is wrong. [KClientError] [REQ_ERR: OPERATION_TIMEDOUT] [KTrafficClient] Something is wrong.